Expanding Selection of Tubulin & TOPI Inhibitor Payloads for Improved Tumor Specific Delivery by Peptide Drug Conjugate
Time: 1:15 pm
day: Conference Day Two
Details:
- Considering the stability of linker-warhead peptide conjugates when working with TOPI inhibitor and tubulin inhibitors
- Improving tumor specificity of warhead delivery for improved therapeutic window
- Describing preclinical efficacy and safety profile, both clinical and non-clinical for Auristatin and Topo1 assets
